Article
CNL and aCML should be considered as a single entity based on molecular profiles and outcomes.
Blood advances - 9 May 2023
Carreño-Tarragona Gonzalo, Álvarez-Larrán Alberto, Harrison Claire, Martínez-Ávila José Carlos, Hernández-Boluda Juan Carlos, Ferrer-Marín Francisca, Radia Deepti H, Mora Elvira, Francis Sebastian, González-Martínez Teresa, Goddard Kathryn, Pérez-Encinas Manuel, Narayanan Srinivasan, Raya José María, Singh Vikram, Gutiérrez Xabier, Toth Peter, Amat-Martínez Paula, Mcilwaine Louisa, Alobaidi Magda, Mayani Karan, McGregor Andrew, Stuckey Ruth, Psaila Bethan, Segura Adrián, Alvares Caroline, Davidson Kerri, Osorio Santiago, Cutting Robert, Sweeney Caroline P, Rufián Laura, Moreno Laura, Cuenca Isabel, Smith Jeffery, Morales María Luz, Gil-Manso Rodrigo, Koutsavlis Ioannis, Wang Lihui, Mead Adam J, Rozman María, Martínez-López Joaquín, Ayala Rosa, Cross Nicholas C P
Abstract excerpt
Chronic neutrophilic leukemia (CNL) and atypical chronic myeloid leukemia (aCML) are rare myeloid disorders that are challenging with regard to diagnosis and clinical management. To study the similarities and differences between these disorders, we undertook a multicenter international study of one of the largest case series (CNL, n = 24; aCML, n = 37 cases, respectively), focusing on the clinical and mutational...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.